V CompBrief BY VELARION

Chief Medical Officer · Avalo Therapeutics, Inc. (AVTX)

Mittie Doyle

FY2025 is the first fiscal year CompBrief holds for Mittie Doyle as a named executive officer of Avalo Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,780,557

4th of 4 named executive officers at Avalo Therapeutics by FY2025 total.

4 named officers on file for Avalo Therapeutics, FY2025

See an example →

What this number hides

The filing gives the total. Avalo Therapeutics’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Avalo Therapeutics’s whole pay program stands against its peers

  • Avalo Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AVTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 10, 2026 (DEF 14A).

Free

Get Mittie Doyle’s full pay file as a PDF — free

More than this page: up to 10 years of Mittie’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Mittie Doyle and every company like it: Velarion Intel, free for 3 days, no card →

Mittie Doyle compensation by year

Avalo Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Avalo Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$512,500
Stock awards$0
Option awards$1,030,429
Non-equity incentive$229,600
All other$8,028
Total$1,780,557

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Avalo Therapeutics, Inc. DEF 14A filed April 10, 2026, accession 0001534120-26-000022, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Avalo Therapeutics, Inc. filed document, accession 0001534120-26-000022. Every figure is read from that document and cited to the page and table it appears in. Filed April 10, 2026.

Avalo Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Garry NeilChief Executive Officer, President and principal executive officer$3,807,581
Taylor BoydChief Business Officer$3,219,751
Mittie FACRChief Medical Officer$1,780,557
Mittie Doyle · this pageChief Medical Officer$1,780,557

Mittie Doyle's compensation dossier, Avalo Therapeutics

You have read Mittie Doyle's totals and holdings. The dossier adds each equity grant Avalo Therapeutics disclosed for Mittie Doyle and Avalo Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Avalo Therapeutics compensation record

free company brief
Avalo Therapeutics, Inc. (AVTX) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within Avalo Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Avalo Therapeutics's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Avalo Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order AVTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Mittie Doyle's compensation dossier